The field of Oncology is one of the most exciting areas of medicine because of the amount of discoveries that are being made every single day. Being a partition of medicine that is abounding with researchers of excellence and all types of backstories and specialties, oncology has scientists like the professor of Oncology at the Rosewell Park Cancer, Mikhail Blagosklonny.Mikhail Blagosklonny is not only a professor at that institute though, as he is also a researcher and one of the most important ones because of his recent study with the Rapamycin drug, also hasn’t called by many specialists by the of Sirolimus.Mikhail has been developing ways, alternative methods for cancer, to use this drug in medicine, and he has discovered that it is a hidden gem that hasn’t been found before the impulse of Mikail to explore the uses of Rapamycin.
Professor of Oncology found out that Rapamycin was only being used as a coating to treat coronary stents and diseases in the lungs as well. Because of healing properties found by the researcher, he realized there was a hidden potential in the drug that was not entirely explored and not enough treatments developed that use Rapamycin as the critical healing component.Oncology also explores the properties of aging and the effects and diseases that come from getting old. Mikhail Blagosklonny is one of the most prominent researchers in that front, and he has been developing, using that newfound multifunctional drug, to develop an anti-aging drug for the future.It is still in very early development phase, but the extreme healing properties of the Rapamycin are showing surprising results in Mikhail Blagosklonny’s reseraches. Before, it was also used to prevent the patient’s body from rejecting an organ transplant, but now, the drug has many additional uses for medicine.
Right now, the drug has already been indicated to be used to treat hemolytic-uremic syndrome: it is a rare syndrome that comes when the user has anemia, and some kind of inefficiency in the kidney, with a combination of low platelet count. Rapamycin can be used for those symptoms before it leads to renal failure and deadlier results. Lymphangioleiomyomatosis (LAM) is another case of study that can use the multifunctional drug to improve therapies and treatments against the disease. It is a very rare disease that attacks the lungs of the patient but it isn’t very deadly or extremely dangerous as it is a very big name. Still, Mikhail Blagosklonny’s improvement of the LAM treatment is a significant victory for medicine.Coronary Stent Coating, Tuberous Sclerosis Complex, and Facial angiofibromas, as well as many types of cancer, are all diseases that have their treatments amplified and improved with the use of Rapamycin to treat the patients. Apart from those therapies that involve the use of highly active and complex therapy sessions, Mikhail has realized that Rapamycin has properties alone that could signal a drug that can extend the longevity of humans.Yes, that is right, Mikhail believes that he has discovered the anti-aging drug of the future.